Aktis Oncology, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +49,490.6% | +0.7% | +298.3% | +62.0% | +63.6% | +49.0% | +125.9% | -14.3% | -11.5% | +166.6% | -18.8% | |
| – | +48,134.2% | -3.1% | +135.6% | +58.5% | +100.4% | +45.2% | +98.5% | +44.4% | -24.4% | +200.2% | -23.4% | |
| – | +47,476.9% | -4.0% | +131.8% | +53.8% | +103.5% | +46.9% | +81.6% | +59.8% | -77.1% | +25.9% | +1.7% | |
| – | +47,476.9% | -4.0% | +131.8% | +53.8% | +103.5% | +46.9% | +81.6% | +59.8% | -23.9% | +203.7% | -23.7% | |
| – | – | – | – | – | +32.8% | +23.2% | +980.6% | – | – | +11.4% | – | |
| – | – | +42.7% | +332.8% | -69.5% | +63.3% | +44.7% | +2,910.3% | – | – | -70.5% | – | |
| – | – | – | – | – | – | – | – | – | – | -55.3% | – | |
| – | – | +129.2% | +189.9% | +28.0% | +46.8% | +40.2% | +1,553.3% | – | – | -17.6% | – | |
| – | +106,977.8% | +469.6% | +65.1% | +401.7% | +42.3% | +36.1% | +93.4% | +172.1% | +7.1% | +145.5% | -0.7% | |
| – | +39,937.3% | +343.7% | +148.5% | +95.9% | +21.5% | +90.6% | +106.5% | -58.3% | +18.2% | +201.8% | +66.0% | |
| – | +0.0% | – | – | – | – | – | -32.3% | +172.8% | +78.9% | -15.2% | +1.5% | |
| – | – | +258.9% | +573.7% | -71.9% | +76.3% | +771.4% | +70.0% | -86.5% | +95.3% | +100.4% | -9.4% | |
| – | +47,490.2% | -36.0% | +460.9% | -7.7% | +87.4% | +59.9% | +149.3% | -118.6% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +5.8% | +27.3% | +23.2% | +31.5% | +22.5% | +60.3% | -35.5% | +0.0% | +0.0% | +50.6% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.